Skip to content
    ADvantage logo

    ADvantage

    Jerusalem, IsraelFounded 2018
    advantage.vcLinkedIn
    Media & EntertainmentGamingConsumer

    ADvantage is a global venture capital fund backing early-stage technology companies aimed at shaping the future of sports. The firm was launched in 2018 by OurCrowd in collaboration with leAD Sports and is based in Jerusalem, Israel.

    Average disclosed round size is $50.0M (across 43 rounds with reported amounts).

    Find people at ADvantage on Goldilocks AI

    Portfolio

    36

    Fund Size

    $50M

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    Alex Bente

    Alex Bente

    Founding partner

    Jeremy Pressman

    Jeremy Pressman

    Founding partner

    Ahron Cohen

    Ahron Cohen

    Venture Partner

    Dr. Laila Mintas

    Dr. Laila Mintas

    Venture Partner

    JW

    John Weaver

    Partner, General Counsel

    Michael Redd

    Michael Redd

    Senior Venture Partner

    Sam Schmelzer

    Sam Schmelzer

    Partner, COO

    Chava Swart

    Chava Swart

    Marketing and Investor Relations

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    49 investments
    CompanyRoundAmountDate
    Dimension Energy logoDimension EnergyGrowth$857MJan 2026
    beatBread logobeatBreadGrowth$124MAug 2025
    Intramotev logoIntramotevSeries A$14.4MAug 2024
    MModifi BiosciencesSeed$4.3MOct 2023
    MODIFI logoMODIFISeed$4.3MOct 2023
    Modifi Bio logoModifi BioSeed$4.3MOct 2023
    Medefy logoMedefySeries A$10MJan 2023
    FlyGuys logoFlyGuysSeries A$13MJan 2023
    Opendorse logoOpendorseUnknown$20MDec 2022
    Torigen Pharmaceuticals logoTorigen PharmaceuticalsUnknown$13MNov 2022
    TTorigenUnknown$13MNov 2022
    RealFevr logoRealFevrUnknown—Jan 2022
    Rooter logoRooterSeries A$25MJan 2022
    MedRhythms logoMedRhythmsSeries B$25MJul 2021
    FlyGuys logoFlyGuysUnknown$2MJan 2021
    GGreenParkSeries A$14MDec 2020
    Recursion Pharmaceuticals logoRecursion PharmaceuticalsSeries D$239MSep 2020
    Talage logoTalageSeries A$5MFeb 2020
    Recursion logoRecursionSeries A$239MJan 2019
    Tappp logoTapppSeries A$5MSep 2018
    Tappp logoTapppSeries A—Jan 2018
    Tappp logoTapppSeries A—Jan 2018
    Recursion Pharmaceuticals logoRecursion PharmaceuticalsSeries B$60MOct 2017
    Recursion logoRecursionSeries B$60MJan 2017
    VVeran Medical TechnologiesGrowth$31MJan 2016
    Page 1 of 2

    Top Co-Investors

    Gaingels6 shared
    Accomplice5 shared
    DCVC4 shared
    Obvious Ventures4 shared
    Mubadala Ventures4 shared
    Lux Capital4 shared
    Two Sigma Ventures4 shared
    Felicis4 shared
    Courtside Ventures4 shared
    359 Capital4 shared
    SignalFire4 shared
    Galaxy Interactive4 shared
    Menlo Ventures3 shared
    Silicon Valley Bank3 shared
    Pentland Group3 shared
    Versant Ventures3 shared
    BrightEdge3 shared
    Casdin Capital2 shared
    Leaps by Bayer2 shared
    Catalio Capital Management2 shared

    Last updated: 20 October 2026